Oxaliplatin and Bolus-Modulated 5-Fluorouracil as a Second-Line Treatment for Advanced Pancreatic Cancer: Can Bolus Regimens Replace FOLFOX When Considered for Second Line?

DOI: 10.1155/2013/358538

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text